Q1 2024 Holdings
Filed 2024-05-15 | 44 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $260.5M | 3,745,262 | 16.2% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $180.4M | 1,587,854 | 11.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $126.1M | 2,909,956 | 7.8% |
| Savara Inc(SVRA) | COM | 805111101 | $121.9M | 24,471,264 | 7.6% |
| Coursera Inc(COUR) | COM | 22266M104 | $108.2M | 12,867,769 | 6.7% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $96.6M | 1,072,936 | 6.0% |
| Verona Pharma PLC(VRNA) | SPONSERED ADS | 925050106 | $89.9M | 5,108,563 | 5.6% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $54.2M | 7,692,298 | 3.4% |
| Nextnav Inc(NN) | COMMON STOCK | 65345N106 | $53.9M | 8,189,156 | 3.3% |
| Cvrx Inc(CVRX) | COM | 126638105 | $43.2M | 2,370,542 | 2.7% |
| Geron Corp(GERN) | COM | 374163103 | $42.2M | 12,776,409 | 2.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $39.2M | 11,370,376 | 2.4% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $38.6M | 3,568,781 | 2.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $27.0M | 1,250,001 | 1.7% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $27.0M | 17,079,778 | 1.7% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $22.6M | 4,448,757 | 1.4% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $20.8M | 14,986,793 | 1.3% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $20.8M | 1,960,169 | 1.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $20.6M | 1,500,000 | 1.3% |
| Zerofox Hldgs Inc | COM | 98955G103 | $20.2M | 18,068,513 | 1.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $19.9M | 3,969,834 | 1.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $18.7M | 15,838,009 | 1.2% |
| Inozyme Pharma Inc | COM | 45790W108 | $18.7M | 2,437,689 | 1.2% |
| Regulus Therapeutics Inc | COM | 75915K200 | $18.6M | 6,467,802 | 1.2% |
| Neuehealth Inc | COM NEW | 10920V404 | $17.7M | 2,726,917 | 1.1% |
| Desktop Metal Inc | COM CL A | 25058X105 | $12.7M | 14,407,594 | 0.8% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $11.5M | 3,835,039 | 0.7% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $10.8M | 2,000,275 | 0.7% |
| Tuya Inc(TUYA) | SPONSERED ADS | 90114C107 | $8.6M | 4,934,640 | 0.5% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $8.4M | 1,713,720 | 0.5% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $7.9M | 4,785,494 | 0.5% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $7.7M | 6,147,260 | 0.5% |
| Buzzfeed Inc | CLASS A COM | 12430A102 | $7.2M | 15,333,892 | 0.4% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $5.7M | 2,382,286 | 0.4% |
| Inventiva SA(IVA) | ADS | 46124U107 | $5.3M | 1,462,586 | 0.3% |
| Synlogic Inc(SYBX) | COM NEW | 87166L209 | $5.2M | 2,922,772 | 0.3% |
| Marker Therapeutics Inc(MRKR) | COM NEW | 57055L206 | $4.6M | 1,071,428 | 0.3% |
| Affimed NV | ORDINARY SHS NEW | N01045207 | $2.3M | 442,649 | 0.1% |
| Senti Biosciences Inc | COM | 81726A100 | $1.7M | 4,426,151 | 0.1% |
| Mynd AI Inc | SPON ADS | 628988107 | $1.6M | 3,642,711 | 0.1% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $926.2K | 419,100 | 0.1% |
| Ikena Oncology Inc | COM | 45175G108 | $809.5K | 570,050 | 0.1% |
| Wheels UP Experience Inc(UP) | COM CL A | 96328L205 | $304.6K | 106,125 | 0.0% |
| Surf AIR Mobility Inc | COM | 868927104 | $185.6K | 220,209 | 0.0% |